[{"id":"7f903bf7-9fc1-43cc-8ff0-c5b59af057ae","acronym":"","url":"https://clinicaltrials.gov/study/NCT04672434","created_at":"2021-01-19T20:44:53.857Z","updated_at":"2024-07-02T16:35:06.328Z","phase":"Phase 1","brief_title":"Sym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies","source_id_and_acronym":"NCT04672434","lead_sponsor":"Symphogen A/S","biomarkers":" MSI","pipe":" | ","alterations":" MSI-H/dMMR","tags":["MSI"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MSI-H/dMMR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e S95024 • Sym021"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 48","initiation":"Initiation: 11/19/2020","start_date":" 11/19/2020","primary_txt":" Primary completion: 12/01/2024","primary_completion_date":" 12/01/2024","study_txt":" Completion: 12/01/2024","study_completion_date":" 12/01/2024","last_update_posted":"2024-05-02"}]